5,5-dimethyl-3-(alpha,alpha,alpha,4-tetrafluoro-3-tolyl)hydantoin has been researched along with Disease Models, Animal in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Dong, Y; Guy, RK; Keiser, J; Lin, MF; Min, J; Muniyan, S; Vargas, M; Vennerstrom, JL; Wang, C; Wang, X; Zhao, Q | 1 |
| Dong, Y; Gautam, N; Keiser, J; Panic, G; Vargas, M; Vennerstrom, JL; Wang, C | 1 |
2 other study(ies) available for 5,5-dimethyl-3-(alpha,alpha,alpha,4-tetrafluoro-3-tolyl)hydantoin and Disease Models, Animal
| Article | Year |
|---|---|
Antischistosomal versus antiandrogenic properties of aryl hydantoin Ro 13-3978.
Topics: Androgen Receptor Antagonists; Animals; Cell Line, Tumor; Cell Proliferation; Dihydrotestosterone; Disease Models, Animal; Humans; Hydantoins; Imidazolidines; Male; Mice; Schistosoma mansoni; Schistosomiasis mansoni; Schistosomicides | 2014 |
Aryl hydantoin Ro 13-3978, a broad-spectrum antischistosomal.
Topics: Animals; Anthelmintics; Disease Models, Animal; Echinostoma; Echinostomiasis; Fasciola hepatica; Fascioliasis; Female; Hydantoins; Mice; Microscopy, Electron, Transmission; Rats; Schistosoma mansoni; Schistosomiasis mansoni; Structure-Activity Relationship; Treatment Outcome | 2015 |